Spring 2025 Prime Therapeutics Report - Prime Therapeutics
Spring 2025 Prime Therapeutics Report
Autoimmune management: Updates and challenges
The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. Our cover story (Page 18) highlights the autoimmune category. As different formulations with different administration routes emerge, it’s increasingly important to manage across the medical and pharmacy benefits. We also discuss updates around biosimilars in the space, including a pipeline.
Other Spring issue highlights:
- Advances and management challenges in gene therapies
- Prime’s IntegratedRx solutions for oncology and cystic fibrosis
- Results from a Prime precision oncology clinical program that evaluated real-world operational processes in biomarker testing
- Update on GLP-1 treatments
- Pipeline update
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.